Technology Innovation for Mechanobiology

Technology Innovation for Mechanobiology2017-10-23T13:24:43+08:00

Engineering novel platforms for experimentation

In order to advance our understanding of mechanobiology it is essential to characterize, in detail, the nano- and micro-scale changes that occur within cells as they respond to changes in their immediate environment. Such an approach requires tools that allow researchers to control or manipulate the physical parameters of a cell’s 3D environment, whilst simultaneously quantifying, with high precision, any changes in cell state. At the MBI we continue to produce innovative platforms that allow experimentation at various levels, from cell layers down to individual proteins.

Researchers at MBI have discovered the differential effects of extracellular matrix (ECM) topography on the proliferation of normal and cancerous cells. Read the full article: A Mechanical STOP Sign.

Particularly valuable is the ability to engineer microfabricated substrates with defined physical properties. These substrates may feature distinct patterns or topology, or comprise pillars that deflect under the force of a moving cell. By controlling the stiffness of the patterned substrate, or the height and flexibility of a pillar array, our researchers have been able to determine the effect the physical environment on cell growth and movement.

New methods for understanding

We have also successfully engineered a chip that allows the growth of single cells or cell doublets in a controlled 3D microenvironment. By using high-end super resolution microscopy to observe the growth and dynamics of single cells/cell doublets, we have characterized the influence of mechanical tension on the formation and function of cadherin-based cell-cell adhesion complexes.

Importantly, the surface chemistry of these microwell arrays can also be defined. This allows us to determine the effect of various components of the extracellular matrix on the growth and adhesive properties of cells in a 3D microenvironment. This approach has been used, for example, to define the development of lumens (tube like spaces) between liver cells.

These microwell arrays have also been adapted by MBI researchers in the development of a novel super-resolution microscopy technique called so-SPIM. Here, the wells are constructed with micro-mirrors, and are able to both direct an excitation beam for fluorescence microscopy, and serve to hold the sample. This method is developed around the principals of selective-plane illumination microscopy. As the micromirror/microwell array is developed independently of the microscope system, this method provides access to super-resolution microscopy, using conventional inverted microscopes.

Diagnostics and Therapetics

MBI is also actively engaging industry partners in the development of new diagnostic tools and therapeutics for a range of diseases. For example, microfluidic chips have been commercialized for use in biomedical assays for the early diagnosis, management, and treatment of cancers, following research conducted by MBI researchers. These devices exploit the differences in the physical properties of various cell types effectively isolate rare cancer cells from a large population of non-cancerous blood cells.

Integrating the knowledge obtained through our basic research programmes with the development of new experimental platforms enables us to innovate technologies that can be used as diagnostic, therapeutic and drug testing platforms in the healthcare industry.

Featured Research in Technology Innovation for Mechanobiology

Technology Innovation for Mechanobiology Researchers

LIM Chwee Teck
Collective cell migration, human disease mechanobiology, microfluidic technologies for disease detection and diagnosis, 2D materials for biomedical applications

YU Hanry
Innovative technologies for diagnostics, therapeutics and drug testing applications in pharmaceutical and healthcare industry

Cell-cell adhesion, microfabrication of controlled environment for cell culture, biophysics of single molecules

MBI Publications in Technology Innovation for Mechanobiology

Latest Publications

  1. Huang X, Lee F, Teng Y, Lingam CB, Chen Z, Sun M, Song Z, Balachander GM, Leo HL, Guo Q, Shah I, and Yu H. Sequential drug delivery for liver diseases. Adv. Drug Deliv. Rev. 2019;. [PMID: 31734169]
  2. Motegi F, Plachta N, and Viasnoff V. Novel approaches to link apicobasal polarity to cell fate specification. Curr. Opin. Cell Biol. 2019; 62:78-85. [PMID: 31731147]
  3. Lim SB, Lim CT, and Lim W. Single-Cell Analysis of Circulating Tumor Cells: Why Heterogeneity Matters. Cancers (Basel) 2019; 11(10). [PMID: 31635038]
  4. Venugopal Menon N, Lim SB, and Lim CT. Microfluidics for personalized drug screening of cancer. Curr Opin Pharmacol 2019; 48:155-161. [PMID: 31634805]
  5. Lim SB, Tan SJ, Lim W, and Lim CT. Compendiums of cancer transcriptomes for machine learning applications. Sci Data 2019; 6(1):194. [PMID: 31594947]
  6. Khoo BL, Bouquerel C, Durai P, Anil S, Goh B, Wu B, Raman L, Mahendran R, Thamboo T, Chiong E, and Lim CT. Detection of Clinical Mesenchymal Cancer Cells from Bladder Wash Urine for Real-Time Detection and Prognosis. Cancers (Basel) 2019; 11(9). [PMID: 31480265]
  7. Rafiq NBM, Grenci G, Lim CK, Kozlov MM, Jones GE, Viasnoff V, and Bershadsky AD. Forces and constraints controlling podosome assembly and disassembly. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 2019; 374(1779):20180228. [PMID: 31431172]
  8. Machado CB, Pluchon P, Harley P, Rigby M, Gonzalez Sabater V, Stevenson DC, Hynes S, Lowe A, Burrone J, Viasnoff V, and Lieberam I. In Vitro Modelling of Nerve-Muscle Connectivity in a Compartmentalised Tissue Culture Device. Adv Biosyst 2019; 3(7). [PMID: 31428672]
  9. Yu L, Feng Y, S/O M Tamil Selven D, Yao L, Soon RH, Yeo JC, and Lim CT. Dual-Core Capacitive Microfiber Sensor for Smart Textile Applications.